Chemotherapy-induced Neutropenia
📧 Sign up to get email alerts when something new happens for Chemotherapy-induced Neutropenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-09-23FDA Approved: NEULASTA — Supplemental Application (Amgen, Inc)
The FDA approved a supplemental application for NEULASTA (pegfilgrastim) submitted by Amgen, Inc.
-
FDA approval · 2014-12-23FDA Approved: NEULASTA — Supplemental Application (Amgen, Inc)
The FDA approved a supplemental application for NEULASTA (pegfilgrastim) filed by Amgen, Inc, allowing changes to the product as described i…
-
FDA approval · 2011-06-03FDA Approved: NEULASTA — Supplemental Application (Amgen, Inc)
The FDA approved a supplemental Biologics License Application for NEULASTA (pegfilgrastim) from Amgen, resulting in labeling updates approve…
-
FDA approval · 2007-07-23FDA Approved: NEULASTA — Supplemental Application (Amgen, Inc)
FDA approved a supplemental application for NEULASTA (pegfilgrastim) from Amgen, authorizing changes to the existing labeling.